Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2.
Senescent cells show an altered secretome profile termed the senescence-associated secretory phenotype (SASP). There is an increasing body of evidence that suggests that the accumulation of SASP-positive senescent cells in humans is partially causal in the observed shift to a low-level pro-inflammat...
Main Authors: | Alimbetov, D, Davis, T, Brook, A, Cox, L, Faragher, R, Nurgozhin, T, Zhumadilov, Z, Kipling, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Verlag
2015
|
Similar Items
-
Small molecule targeting of the p38/Mk2 stress signaling pathways to improve cancer treatment
by: D. Alimbetov, et al.
Published: (2023-09-01) -
The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?
by: Naoko Ohtani
Published: (2022-04-01) -
Sensitive detection and monitoring of senescence-associated secretory phenotype by SASP-RAP assay.
by: Liubao Gu, et al.
Published: (2012-01-01) -
Optimisation of a screening platform for determining IL-6 inflammatory signalling in the senescence-associated secretory phenotype (SASP)
by: Rolt, A, et al.
Published: (2019) -
Senescent Endothelial Cells Sustain Their Senescence-Associated Secretory Phenotype (SASP) through Enhanced Fatty Acid Oxidation
by: Angelica Giuliani, et al.
Published: (2023-11-01)